| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.728 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.716 | |
| chemotaxis | GO:0006935 | 247 | 0.685 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.608 | |
| developmental maturation | GO:0021700 | 193 | 0.607 | |
| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 | 0.544 | |
| neural tube closure | GO:0001843 | 90 | 0.539 | |
| epithelial tube formation | GO:0072175 | 130 | 0.531 | |
| neural tube formation | GO:0001841 | 108 | 0.506 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.496 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.478 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.464 | |
| neuron projection guidance | GO:0097485 | 141 | 0.456 | |
| central nervous system projection neuron axonogenesis | GO:0021952 | 21 | 0.442 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.408 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.380 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.379 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.377 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.360 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.343 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.342 | |
| anterior commissure morphogenesis | GO:0021960 | 6 | 0.333 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.332 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.323 | |
| stem cell development | GO:0048864 | 219 | 0.320 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.304 | |
| tube formation | GO:0035148 | 140 | 0.299 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.289 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.283 | |
| cell adhesion | GO:0007155 | 329 | 0.273 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.268 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.262 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.262 | |
| neural tube development | GO:0021915 | 160 | 0.259 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.258 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.257 | |
| axonogenesis | GO:0007409 | 274 | 0.255 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.254 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.250 | |
| stem cell differentiation | GO:0048863 | 268 | 0.245 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.244 | |
| synapse organization | GO:0050808 | 125 | 0.242 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.240 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.239 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.236 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.230 | |
| gonad development | GO:0008406 | 141 | 0.229 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.228 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.226 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.225 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.224 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.218 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.215 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.214 | |
| stem cell proliferation | GO:0072089 | 117 | 0.213 | |
| primary neural tube formation | GO:0014020 | 95 | 0.212 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.212 | |
| telencephalon development | GO:0021537 | 186 | 0.211 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.209 | |
| renal tubule development | GO:0061326 | 87 | 0.206 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.205 | |
| fasciculation of motor neuron axon | GO:0097156 | 2 | 0.203 | |
| gtp catabolic process | GO:0006184 | 143 | 0.194 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.191 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.187 | |
| somite development | GO:0061053 | 81 | 0.187 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.185 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.184 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.183 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.182 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.181 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.179 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.172 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.172 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.170 | |
| skeletal system development | GO:0001501 | 356 | 0.168 | |
| positive regulation of ureteric bud formation | GO:0072107 | 3 | 0.167 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.166 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.165 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.161 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.158 | |
| histone modification | GO:0016570 | 159 | 0.154 | |
| semaphorin plexin signaling pathway | GO:0071526 | 21 | 0.154 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.153 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.151 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.149 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.148 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.148 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.147 | |
| spinal cord development | GO:0021510 | 81 | 0.144 | |
| dendritic spine development | GO:0060996 | 30 | 0.143 | |
| cell cell signaling involved in mammary gland development | GO:0060764 | 2 | 0.142 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.142 | |
| cerebral cortex development | GO:0021987 | 86 | 0.142 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.141 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.141 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.138 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.137 | |
| forebrain development | GO:0030900 | 302 | 0.135 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.134 | |
| angiogenesis | GO:0001525 | 201 | 0.133 | |
| regionalization | GO:0003002 | 337 | 0.133 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.131 | |
| dendritic spine organization | GO:0097061 | 26 | 0.131 | |
| ureteric bud development | GO:0001657 | 94 | 0.130 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.129 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.127 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.127 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.127 | |
| fat cell differentiation | GO:0045444 | 160 | 0.127 | |
| bone mineralization | GO:0030282 | 54 | 0.127 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.126 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.124 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.124 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.124 | |
| nephron tubule formation | GO:0072079 | 20 | 0.123 | |
| gtp metabolic process | GO:0046039 | 144 | 0.121 | |
| semaphorin plexin signaling pathway involved in bone trabecula morphogenesis | GO:1900220 | 2 | 0.121 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.121 | |
| gland development | GO:0048732 | 330 | 0.119 | |
| intestinal epithelial cell maturation | GO:0060574 | 2 | 0.118 | |
| mesonephros development | GO:0001823 | 97 | 0.117 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.116 | |
| amine metabolic process | GO:0009308 | 45 | 0.116 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.115 | |
| epithelial cell development | GO:0002064 | 159 | 0.114 | |
| vagus nerve development | GO:0021564 | 3 | 0.114 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.114 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.113 | |
| regulation of cell migration | GO:0030334 | 219 | 0.113 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.112 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.111 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.111 | |
| atrioventricular valve morphogenesis | GO:0003181 | 13 | 0.110 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.110 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.110 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.109 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.109 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.108 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.108 | |
| heart valve development | GO:0003170 | 23 | 0.107 | |
| regulation of cell activation | GO:0050865 | 289 | 0.107 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.106 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.106 | |
| ossification | GO:0001503 | 216 | 0.105 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.104 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.103 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.101 | |
| stem cell maintenance | GO:0019827 | 130 | 0.101 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.101 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.099 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.098 | |
| lung development | GO:0030324 | 164 | 0.098 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.098 | |
| neuron death | GO:0070997 | 154 | 0.098 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.098 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.097 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.096 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.096 | |
| regulation of cell motility | GO:2000145 | 236 | 0.095 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.094 | |
| biomineral tissue development | GO:0031214 | 64 | 0.093 | |
| parathyroid hormone secretion | GO:0035898 | 2 | 0.092 | |
| epidermis development | GO:0008544 | 187 | 0.092 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.092 | |
| kidney development | GO:0001822 | 213 | 0.091 | |
| compound eye development | GO:0048749 | 1 | 0.091 | |
| neuron projection extension involved in neuron projection guidance | GO:1902284 | 14 | 0.091 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.091 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.090 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.090 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.089 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.089 | |
| central nervous system neuron axonogenesis | GO:0021955 | 28 | 0.089 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.089 | |
| synapse assembly | GO:0007416 | 56 | 0.088 | |
| axon guidance | GO:0007411 | 141 | 0.088 | |
| cell maturation | GO:0048469 | 127 | 0.087 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.087 | |
| regulation of osteoblast proliferation | GO:0033688 | 15 | 0.086 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.086 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.086 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.085 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.085 | |
| hindbrain development | GO:0030902 | 128 | 0.085 | |
| limbic system development | GO:0021761 | 72 | 0.085 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.085 | |
| gliogenesis | GO:0042063 | 141 | 0.085 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.085 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.085 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.085 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.084 | |
| wnt signaling pathway involved in somitogenesis | GO:0090244 | 4 | 0.084 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.083 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.083 | |
| nephron epithelium development | GO:0072009 | 92 | 0.083 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.082 | |
| sympathetic nervous system development | GO:0048485 | 22 | 0.082 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.082 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.082 | |
| regulation of neuron death | GO:1901214 | 134 | 0.082 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.081 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.081 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.080 | |
| epithelial cell migration | GO:0010631 | 63 | 0.080 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.079 | |
| sensory perception | GO:0007600 | 245 | 0.079 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.078 | |
| cellular homeostasis | GO:0019725 | 240 | 0.078 | |
| skin development | GO:0043588 | 220 | 0.077 | |
| regulation of ossification | GO:0030278 | 112 | 0.077 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.077 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.076 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.076 | |
| dna repair | GO:0006281 | 107 | 0.076 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.076 | |
| parasympathetic nervous system development | GO:0048486 | 19 | 0.075 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.075 | |
| renal system development | GO:0072001 | 225 | 0.075 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.075 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.074 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.074 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.074 | |
| somitogenesis | GO:0001756 | 69 | 0.074 | |
| regulation of protein localization | GO:0032880 | 231 | 0.073 | |
| regulation of binding | GO:0051098 | 111 | 0.072 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.072 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.072 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.072 | |
| mesenchyme development | GO:0060485 | 152 | 0.072 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.071 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.071 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.071 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.071 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.070 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.070 | |
| regulation of cell shape | GO:0008360 | 39 | 0.070 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.070 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.070 | |
| branchiomotor neuron axon guidance | GO:0021785 | 7 | 0.070 | |
| nephron development | GO:0072006 | 109 | 0.069 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.069 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.069 | |
| mitral valve development | GO:0003174 | 4 | 0.069 | |
| locomotory behavior | GO:0007626 | 195 | 0.068 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.068 | |
| cellular response to lipid | GO:0071396 | 145 | 0.068 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.068 | |
| regulation of secretion | GO:0051046 | 274 | 0.067 | |
| negative regulation of dendritic spine morphogenesis | GO:0061002 | 3 | 0.067 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.067 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.066 | |
| blood coagulation | GO:0007596 | 76 | 0.066 | |
| protein targeting | GO:0006605 | 143 | 0.066 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.065 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.065 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.065 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.065 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.065 | |
| bone marrow development | GO:0048539 | 3 | 0.064 | |
| bone development | GO:0060348 | 120 | 0.064 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.064 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.064 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.063 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.063 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.062 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.062 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.062 | |
| tissue migration | GO:0090130 | 68 | 0.062 | |
| osteoblast proliferation | GO:0033687 | 18 | 0.062 | |
| coagulation | GO:0050817 | 78 | 0.062 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.061 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.061 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.061 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.061 | |
| preganglionic parasympathetic nervous system development | GO:0021783 | 17 | 0.061 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.061 | |
| glial cell differentiation | GO:0010001 | 131 | 0.061 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.061 | |
| blastocyst development | GO:0001824 | 80 | 0.060 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.060 | |
| immune effector process | GO:0002252 | 321 | 0.060 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.060 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.060 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.059 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.059 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.059 | |
| clara cell differentiation | GO:0060486 | 4 | 0.059 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.059 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.058 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.058 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.058 | |
| nephric duct formation | GO:0072179 | 4 | 0.058 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.057 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.057 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.056 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.056 | |
| regulation of store operated calcium entry | GO:2001256 | 4 | 0.056 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.056 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.056 | |
| cation homeostasis | GO:0055080 | 212 | 0.056 | |
| renal vesicle induction | GO:0072034 | 3 | 0.056 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.055 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.055 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.055 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.055 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.055 | |
| female sex determination | GO:0030237 | 1 | 0.055 | |
| chemorepulsion of branchiomotor axon | GO:0021793 | 1 | 0.055 | |
| heart valve formation | GO:0003188 | 10 | 0.055 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.054 | |
| regulation of axon guidance | GO:1902667 | 13 | 0.054 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.054 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.054 | |
| regulation of dendritic spine development | GO:0060998 | 22 | 0.054 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.053 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.053 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.053 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.053 | |
| rhombomere formation | GO:0021594 | 1 | 0.053 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.053 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.053 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.052 | |
| intracellular protein transport | GO:0006886 | 204 | 0.052 | |
| facial nerve development | GO:0021561 | 11 | 0.052 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.051 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.051 | |
| hemostasis | GO:0007599 | 78 | 0.051 | |
| lung morphogenesis | GO:0060425 | 50 | 0.051 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.050 | |
| platelet activation | GO:0030168 | 40 | 0.050 | |
| membrane organization | GO:0061024 | 245 | 0.050 | |
| female sex differentiation | GO:0046660 | 84 | 0.050 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.050 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.050 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.049 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.049 | |
| nephron tubule development | GO:0072080 | 84 | 0.049 | |
| semaphorin plexin signaling pathway involved in neuron projection guidance | GO:1902285 | 6 | 0.049 | |
| positive regulation of binding | GO:0051099 | 49 | 0.048 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.048 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.048 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.048 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.048 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.048 | |
| dna metabolic process | GO:0006259 | 303 | 0.048 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.048 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.047 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.047 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.047 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.047 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.046 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.046 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.046 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.046 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.046 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.045 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.045 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.045 | |
| commissural neuron axon guidance | GO:0071679 | 8 | 0.045 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.045 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.045 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.045 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.044 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.044 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.044 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.044 | |
| cell recognition | GO:0008037 | 83 | 0.044 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.043 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.043 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.043 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.043 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.043 | |
| heart morphogenesis | GO:0003007 | 178 | 0.043 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.042 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.042 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.042 | |
| epithelium migration | GO:0090132 | 63 | 0.042 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.042 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.042 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.041 | |
| cytokine secretion | GO:0050663 | 72 | 0.041 | |
| mesonephric tubule formation | GO:0072172 | 11 | 0.041 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.041 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.041 | |
| negative regulation of catenin import into nucleus | GO:0035414 | 2 | 0.041 | |
| leukocyte migration | GO:0050900 | 124 | 0.041 | |
| nuclear transport | GO:0051169 | 139 | 0.041 | |
| t cell activation | GO:0042110 | 289 | 0.041 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.040 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.040 | |
| endothelial cell migration | GO:0043542 | 44 | 0.040 | |
| thymus development | GO:0048538 | 41 | 0.040 | |
| protein import into nucleus | GO:0006606 | 95 | 0.040 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.040 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.040 | |
| myotube differentiation | GO:0014902 | 105 | 0.039 | |
| regulation of protein transport | GO:0051223 | 163 | 0.039 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.039 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.039 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.038 | |
| single organism nuclear import | GO:1902593 | 95 | 0.038 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.038 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.038 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.038 | |
| neural crest cell migration | GO:0001755 | 32 | 0.037 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.037 | |
| lung cell differentiation | GO:0060479 | 30 | 0.037 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.037 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.037 | |
| positive regulation of wnt signaling pathway planar cell polarity pathway | GO:2000096 | 5 | 0.037 | |
| hindbrain tangential cell migration | GO:0021934 | 2 | 0.037 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.037 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.037 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.036 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.036 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.036 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.036 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.036 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.036 | |
| hypothalamic tangential migration using cell axon interactions | GO:0021856 | 3 | 0.036 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.036 | |
| limb morphogenesis | GO:0035108 | 149 | 0.035 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.035 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.035 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.035 | |
| septum primum development | GO:0003284 | 4 | 0.035 | |
| respiratory system development | GO:0060541 | 190 | 0.035 | |
| lipid localization | GO:0010876 | 126 | 0.035 | |
| regulation of gamma aminobutyric acid secretion | GO:0014052 | 2 | 0.035 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.035 | |
| columnar cuboidal epithelial cell maturation | GO:0002069 | 4 | 0.035 | |
| gastrulation | GO:0007369 | 116 | 0.035 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.034 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.034 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.034 | |
| kidney epithelium development | GO:0072073 | 121 | 0.034 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.034 | |
| protein localization to organelle | GO:0033365 | 185 | 0.034 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.034 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.034 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.034 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.034 | |
| axis elongation | GO:0003401 | 30 | 0.034 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.034 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.034 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.034 | |
| t cell differentiation | GO:0030217 | 174 | 0.033 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.033 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.033 | |
| dendritic spine morphogenesis | GO:0060997 | 22 | 0.033 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.033 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.033 | |
| cranial nerve development | GO:0021545 | 41 | 0.033 | |
| cerebral cortex tangential migration using cell axon interactions | GO:0021824 | 3 | 0.033 | |
| renal vesicle morphogenesis | GO:0072077 | 15 | 0.033 | |
| axon extension involved in axon guidance | GO:0048846 | 14 | 0.033 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.032 | |
| negative chemotaxis | GO:0050919 | 14 | 0.032 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.032 | |
| regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | GO:2000702 | 1 | 0.032 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.032 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.032 | |
| facial nerve structural organization | GO:0021612 | 10 | 0.032 | |
| ephrin receptor signaling pathway | GO:0048013 | 20 | 0.032 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.032 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.031 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.031 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.031 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.031 | |
| segmentation | GO:0035282 | 93 | 0.031 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.031 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.031 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.031 | |
| fungiform papilla development | GO:0061196 | 6 | 0.031 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.030 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.030 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.030 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.030 | |
| endocrine system development | GO:0035270 | 98 | 0.030 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.030 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.030 | |
| dendrite development | GO:0016358 | 115 | 0.030 | |
| regulation of ion transport | GO:0043269 | 215 | 0.030 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.030 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.030 | |
| pallium development | GO:0021543 | 120 | 0.030 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.030 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.030 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.029 | |
| regulation of protein binding | GO:0043393 | 60 | 0.029 | |
| forebrain neuron development | GO:0021884 | 30 | 0.029 | |
| cell cell junction organization | GO:0045216 | 72 | 0.029 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.029 | |
| regulation of dendritic spine morphogenesis | GO:0061001 | 17 | 0.029 | |
